H.R. 3269

119th CongressIn committee

ETHIC Act

Sponsored by Jodey C. Arrington (Republican-TX-19)

Trade & Manufacturing

Cosponsors

Actions

Roll calls

Amendments

Related bills

Actions

May 8, 2025 · Library of Congress

Introduced in House

May 8, 2025 · Library of Congress

Introduced in House

May 8, 2025 · House floor actions

Referred to the House Committee on the Judiciary.

Latest activity

Activity

July 2026

Lobbying reported · Biotechnology Innovation Organization · Jul 21

Biotechnology Innovation Organization reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $2,360,000

Lobbying reported · Association for Accessible Medicines · Jul 20

Association for Accessible Medicines reported 2nd Quarter (Apr 1 - June 30) lobbying for Association for Accessible Medicines — $870,000

BillsH.R. 3160 H.R. 3269 H.R. 5526 H.R. 5811 H.R. 6485 H.R. 7148 H.R. 8269 H.R. 8339 S. 43 S. 1096 S. 1546 S. 1553 S. 1954 S. 2658 S. 3469 S. 3788

Lobbying reported · Bayer · Jul 20

Bayer reported 2nd Quarter (Apr 1 - June 30) lobbying for Bayer — $1,820,000

BillsH.R. 1492 H.R. 1897 H.R. 3160 H.R. 3269 H.R. 7366 H.R. 7567 H.R. 9171 H.R. 9260 S. 832 S. 1546 S. 1553 S. 3677 S. 3788

Lobbying reported · Kaiser Foundation Health Plan · Jul 20

Kaiser Foundation Health Plan reported 2nd Quarter (Apr 1 - June 30) lobbying for Kaiser Foundation Health Plan — $530,000

BillsH.R. 3269 H.R. 3514 H.R. 5429 H.R. 5526 H.R. 5582 H.R. 6248 H.R. 6644 H.R. 7148 H.R. 8800 H.R. 9393 H.R. 9504 S. 43 S. 1816 S. 1954 S. 2355 S. 2620 S. 2780 S. 3014 S. 3822 S. 4027 S. 4784

Lobbying reported · Chamber Of Commerce Of The U.s.a. · Jul 20

Chamber Of Commerce Of The U.s.a. reported 2nd Quarter (Apr 1 - June 30) lobbying for Chamber Of Commerce Of The U.s.a. — $16,950,000

BillsH.Con.Res. 34 H.J.Res. 35 H.J.Res. 59 H.J.Res. 61 H.J.Res. 74 H.J.Res. 87 H.J.Res. 88 H.J.Res. 89 H.R. 33 H.R. 77 H.R. 161 H.R. 278 H.R. 448 H.R. 471 H.R. 640 H.R. 755 H.R. 804 H.R. 1013 H.R. 1047 H.R. 1070 H.R. 1109 H.R. 1152 H.R. 1163 H.R. 1190 H.R. 1335 H.R. 1340 H.R. 1343 H.R. 1469 H.R. 1588 H.R. 1665 H.R. 1681 H.R. 1687 H.R. 1721 H.R. 1731 H.R. 1799 H.R. 1897 H.R. 1949 H.R. 2089 H.R. 2145 H.R. 2213 H.R. 2225 H.R. 2289 H.R. 2308 H.R. 2385 H.R. 2467 H.R. 2528 H.R. 2548 H.R. 2612 H.R. 2617 H.R. 2635 H.R. 2651 H.R. 2675 H.R. 2696 H.R. 2709 H.R. 2794 H.R. 2799 H.R. 2804 H.R. 2853 H.R. 2854 H.R. 2940 H.R. 2964 H.R. 2986 H.R. 3015 H.R. 3062 H.R. 3109 H.R. 3209 H.R. 3227 H.R. 3269 H.R. 3301 H.R. 3339 H.R. 3343 H.R. 3351 H.R. 3352 H.R. 3381 H.R. 3382 H.R. 3383 H.R. 3394 H.R. 3446 H.R. 3447 H.R. 3512 H.R. 3552 H.R. 3616 H.R. 3617 H.R. 3628 H.R. 3632 H.R. 3638 H.R. 3645 H.R. 3657 H.R. 3668 H.R. 3673 H.R. 3682 H.R. 3699 H.R. 3862 H.R. 3898 H.R. 3899 H.R. 3959 H.R. 4016 H.R. 4109 H.R. 4121 H.R. 4168 H.R. 4171 H.R. 4213 H.R. 4214 H.R. 4218 H.R. 4357 H.R. 4386 H.R. 4393 H.R. 4409 H.R. 4429 H.R. 4430 H.R. 4431 H.R. 4437 H.R. 4466 H.R. 4478 H.R. 4503 H.R. 4553 H.R. 4661 H.R. 4669 H.R. 4754 H.R. 4767 H.R. 4776 H.R. 4806 H.R. 5077 H.R. 5166 H.R. 5258 H.R. 5270 H.R. 5408 H.R. 5437 H.R. 5463 H.R. 5484 H.R. 5494 H.R. 5551 H.R. 5631 H.R. 5689 H.R. 5764 H.R. 5784 H.R. 5926 H.R. 6055 H.R. 6084 H.R. 6129 H.R. 6194 H.R. 6294 H.R. 6333 H.R. 6336 H.R. 6373 H.R. 6387 H.R. 6398 H.R. 6409 H.R. 6453 H.R. 6461 H.R. 6500 H.R. 6504 H.R. 6553 H.R. 6623 H.R. 6644 H.R. 6955 H.R. 7023 H.R. 7056 H.R. 7084 H.R. 7085 H.R. 7127 H.R. 7128 H.R. 7257 H.R. 7258 H.R. 7266 H.R. 7291 H.R. 7305 H.R. 7390 H.R. 7450 H.R. 7502 H.R. 7567 H.R. 7688 H.R. 7845 H.R. 8013 H.R. 8045 H.R. 8101 H.R. 8183 H.R. 8210 H.R. 8286 H.R. 8324 H.R. 8338 H.R. 8389 H.R. 8413 H.R. 8477 H.R. 8624 H.R. 8673 H.R. 8714 H.R. 8780 H.R. 8790 H.R. 8800 H.R. 8870 H.R. 9194 H.R. 9224 H.R. 9238 H.R. 9250 H.R. 9310 H.R. 9317 S. 199 S. 351 S. 424 S. 492 S. 495 S. 577 S. 714 S. 796 S. 844 S. 985 S. 1071 S. 1241 S. 1323 S. 1367 S. 1404 S. 1462 S. 1596 S. 1686 S. 1705 S. 1748 S. 1808 S. 1839 S. 1843 S. 1847 S. 1877 S. 2228 S. 2260 S. 2296 S. 2511 S. 2651 S. 2658 S. 2714 S. 2827 S. 2828 S. 2875 S. 2924 S. 2934 S. 3170 S. 3180 S. 3305 S. 3332 S. 3404 S. 3578 S. 3605 S. 3671 S. 3800 S. 3808 S. 3822 S. 3826 S. 3841 S. 3931 S. 3947 S. 3967 S. 3971 S. 4016 S. 4055 S. 4071 S. 4217 S. 4221 S. 4360 S. 4463 S. 4506 S. 4615 S. 4639 S. 4746 S. 4753 S. 4784 S. 4815 S. 4850 S.Con.Res. 14 S.J.Res. 11 S.J.Res. 12 S.J.Res. 18 S.J.Res. 28 S.J.Res. 36 S.J.Res. 45 S.J.Res. 46 S.J.Res. 47 S.J.Res. 55

Lobbying reported · Fresenius Kabi USA · Jul 20

Fresenius Kabi USA reported 2nd Quarter (Apr 1 - June 30) lobbying for Fresenius Kabi USA — $580,000

BillsH.R. 3269 H.R. 5526 S. 1954 S. 2658

Lobbying reported · Amgen · Jul 20

Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000

Lobbying reported · Johnson & Johnson Services · Jul 20

Johnson & Johnson Services reported 2nd Quarter (Apr 1 - June 30) lobbying for Johnson & Johnson Services — $1,440,000

Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20

Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000

Lobbying reported · American Intellectual Property Law Association · Jul 20

American Intellectual Property Law Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Intellectual Property Law Association — $10,000

BillsH.R. 1109 H.R. 1566 H.R. 2675 H.R. 3160 H.R. 3269 H.R. 4930 H.R. 5794 H.R. 5811 H.R. 6028 H.R. 6485 H.R. 6517 H.R. 7140 S. 43 S. 1096 S. 1367 S. 1546 S. 1553 S. 2677 S. 3517

Lobbying reported · Novartis · Jul 20

Novartis reported 2nd Quarter (Apr 1 - June 30) lobbying for Novartis — $1,410,000

Lobbying reported · American Society Of Health-System Pharmacists · Jul 20

American Society Of Health-System Pharmacists reported 2nd Quarter (Apr 1 - June 30) lobbying for American Society Of Health-System Pharmacists — $260,000

Lobbying reported · Public Citizen · Jul 20

Public Citizen reported 2nd Quarter (Apr 1 - June 30) lobbying for Public Citizen — $99,577

Lobbying reported · Nfib (national Federation Of Independent Business) · Jul 20

Nfib (national Federation Of Independent Business) reported 2nd Quarter (Apr 1 - June 30) lobbying for Nfib (national Federation Of Independent Business) — $1,670,000

Lobbying reported · Council for Innovation Promotion · Jul 20

Council for Innovation Promotion reported 2nd Quarter (Apr 1 - June 30) lobbying for Council for Innovation Promotion — $90,000

BillsH.R. 861 H.R. 2794 H.R. 3269 H.R. 4370 H.R. 4780 H.R. 6485 H.R. 9221 H.R. 9474 S. 43 S. 527 S. 1040 S. 1367 S. 2140 S. 2220 S. 2780 S. 4840

Lobbying reported · Yc Consulting · Jul 20

Yc Consulting reported 2nd Quarter (Apr 1 - June 30) lobbying for Genentech — $50,000

BillsH.R. 3269

Lobbying reported · Mehlman Consulting · Jul 17

Mehlman Consulting reported 2nd Quarter (Apr 1 - June 30) lobbying for Association Of Accessible Medicines — $60,000

BillsH.R. 1843 H.R. 3269 H.R. 5526 S. 43 S. 1040 S. 1302 S. 1954

Lobbying reported · S-3 Group · Jul 17

S-3 Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Fresenius Kabi — $30,000

BillsH.R. 3269 S. 2658

Lobbying reported · Glaxosmithkline · Jul 16

Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000

Lobbying reported · Intellectual Property Owners Association · Jul 15

Intellectual Property Owners Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Intellectual Property Owners Association — $50,000

BillsH.R. 1566 H.R. 3160 H.R. 3269 H.R. 5155 H.R. 6485 H.R. 7015 H.R. 7389 H.R. 8800 S. 43 S. 1379 S. 1546 S. 1553 S. 2658 S. 3826 S. 4784